1Department of Medicine,
2Department of Radiology, Abdominal Imaging Division,
3Department of Pathology, Anatomy, & Cell Biology,
4Department of Medical Oncology,
Correspondence Address: Dr. Hie-Won Hann, FAASLD, Professor of Medicine, Liver Disease Prevention Center, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA. E-mail: email@example.com
© The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
The Case Report was published on 21 Jun 2019.
The author's statement of conflict of interest was confused with the original and published incorrectly due to the negligence of the Editorial Office. Here is the correction:
Conflict of Interest:
Hie-Won Hann: Clinical Research Grant from Gilead, Assembly Biosciences, Arbutus and serves at the National Advisory Board of Gilead Sciences.
Ralph Zinner: Bristol Myers Squibb, Merck
Peter Block, Brianna Shinn, Christopher Roth, Jeffrey Baliff: No conflict of Interest.
We, Editorial Office of Hepatoma Research apologize for any inconvenience we may cause.
Block PD, Shinn BJ, Roth CG, Baliff JP, Zinner RG, Hann HW. Correction: Three primary malignancies in 17 years in a man with chronic hepatitis B. Hepatoma Res 2019;5:22. http://dx.doi.org/10.20517/2394-5079.2019.017
Full-Text Views Each Month
PDF Downloads Each Month